テモゾロミド (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "テモゾロミド" in Japanese language version.

refsWebsite

Global rank Japanese rank

25nih.gov

4^th place

24^th place

20doi.org

2^nd place

6^th place

2wikipedia.org

low place

2aacrjournals.org

8,869^th place

low place

1nejm.org

2,374^th place

2,486^th place

1web.archive.org

1^st place

1unil.ch

9,112^th place

low place

1elsevier.com

610^th place

915^th place

1clinicaltrials.gov

5,225^th place

low place

1fhcrc.org

low place

1springerlink.com

2,569^th place

2,101^st place

1harvard.edu

18^th place

107^th place

aacrjournals.org (Global: 8,869^th place; Japanese: low place)

cancerres.aacrjournals.org

Pyrko P, Schönthal AH, Hofman FM, Chen TC, Lee AS (October 2007). “The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas”. Cancer Res. 67 (20): 9809–16. doi:10.1158/0008-5472.CAN-07-0625. PMID 17942911.

mct.aacrjournals.org

Ueno T, Ko SH, Grubbs E, and others (March 2006). “Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine”. Mol. Cancer Ther. 5 (3): 732–8. doi:10.1158/1535-7163.MCT-05-0098. PMID 16546988.

clinicaltrials.gov (Global: 5,225^th place; Japanese: low place)

“Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)”. ClinicalTrials.gov (2011年11月). 2014年10月21日閲覧。

doi.org (Global: 2^nd place; Japanese: 6^th place)

Jacinto, FV; Esteller, M (August 2007). “MGMT hypermethylation: a prognostic foe, a predictive friend.”. DNA Repair 6 (8): 1155–60. doi:10.1016/j.dnarep.2007.03.013. PMID 17482895.
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (March 2005). “MGMT gene silencing and benefit from temozolomide in glioblastoma”. N. Engl. J. Med. 352 (10): 997–1003. doi:10.1056/NEJMoa043331. PMID 15758010.
National Cancer Institute Of Canada Clinical Trials, Group; Hegi, ME; Mason, WP; Van Den Bent, MJ; Taphoorn, MJ; Janzer, RC; Ludwin, SK; Allgeier, A et al. (May 2009). “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial”. Lancet Oncology 10 (5): 459–466. doi:10.1016/S1470-2045(09)70025-7. PMID 19269895.
“[Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma”] (English). N Engl J Med: 987-996. (March 2005). doi:10.1056/NEJMoa043330.
“Balancing repair and tolerance of DNA damage caused by alkylating agents”. Nature Reviews. Cancer 12 (2): 104–120. (January 2012). doi:10.1038/nrc3185. PMC 3586545. PMID 22237395.
“DNA mismatch repair and the DNA damage response”. DNA Repair 38: 94–101. (February 2016). doi:10.1016/j.dnarep.2015.11.019. PMC 4740233. PMID 26704428.
“MGMT hypermethylation: a prognostic foe, a predictive friend”. DNA Repair 6 (8): 1155–1160. (August 2007). doi:10.1016/j.dnarep.2007.03.013. PMID 17482895.
“MGMT gene silencing and benefit from temozolomide in glioblastoma”. The New England Journal of Medicine 352 (10): 997–1003. (March 2005). doi:10.1056/NEJMoa043331. PMID 15758010. オリジナルの26 April 2019時点におけるアーカイブ。 2022年4月9日閲覧。.
“Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial”. The Lancet. Oncology 10 (5): 459–466. (May 2009). doi:10.1016/S1470-2045(09)70025-7. PMID 19269895.
“[Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide”] (French). Gynecol Obstet Fertil 38 (11): 660–2. (November 2010). doi:10.1016/j.gyobfe.2010.09.002. PMID 21030284.
Gilbert MR (March 2006). “New treatments for malignant gliomas: careful evaluation and cautious optimism required”. Ann. Intern. Med. 144 (5): 371–3. doi:10.7326/0003-4819-144-5-200603070-00015. PMID 16520480.
Pyrko P, Schönthal AH, Hofman FM, Chen TC, Lee AS (October 2007). “The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas”. Cancer Res. 67 (20): 9809–16. doi:10.1158/0008-5472.CAN-07-0625. PMID 17942911.
Sheehan J, Cifarelli C, Dassoulas K, Olson C, Rainey J, Han S (2010). “Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide”. Journal of Neurosurgery 113 (2): 234–239. doi:10.3171/2009.11.JNS091314. PMID 20001586.
Ueno T, Ko SH, Grubbs E, and others (March 2006). “Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine”. Mol. Cancer Ther. 5 (3): 732–8. doi:10.1158/1535-7163.MCT-05-0098. PMID 16546988.
Friedman, HS; Jiang, SX; Reardon, DA; Desjardins, A; Vredenburgh, JJ; Rich, JN; Gururangan, S; Friedman, AH et al. (March 2009). “Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma”. J. Clin. Oncol. 27 (8): 1262–7. doi:10.1200/JCO.2008.18.8417. PMC 2667825. PMID 19204199.
Dall'oglio S, D'Amico A, Pioli F, Gabbani M, Pasini F, Passarin MG, Talacchi A, Turazzi S, Maluta S (December 2008). “Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas”. J Neurooncol 90 (3): 315–9. doi:10.1007/s11060-008-9663-9. PMID 18688571.
“New treatments for malignant gliomas: careful evaluation and cautious optimism required”. Annals of Internal Medicine 144 (5): 371–373. (March 2006). doi:10.7326/0003-4819-144-5-200603070-00015. PMID 16520480.
“The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas”. Cancer Research 67 (20): 9809–9816. (October 2007). doi:10.1158/0008-5472.CAN-07-0625. PMID 17942911.
“Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide”. Journal of Neurosurgery 113 (2): 234–239. (August 2010). doi:10.3171/2009.11.JNS091314. PMID 20001586.
“Mechanisms and therapeutic implications of hypermutation in gliomas”. Nature 580 (7804): 517–523. (April 2020). Bibcode: 2020Natur.580..517T. doi:10.1038/s41586-020-2209-9. PMC 8235024. PMID 32322066.

elsevier.com (Global: 610^th place; Japanese: 915^th place)

linkinghub.elsevier.com

“[Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide”] (French). Gynecol Obstet Fertil 38 (11): 660–2. (November 2010). doi:10.1016/j.gyobfe.2010.09.002. PMID 21030284.

fhcrc.org (Global: low place; Japanese: low place)

labs.fhcrc.org

http://labs.fhcrc.org/kiem/Hans-Peter_Kiem.html

harvard.edu (Global: 18^th place; Japanese: 107^th place)

ui.adsabs.harvard.edu

“Mechanisms and therapeutic implications of hypermutation in gliomas”. Nature 580 (7804): 517–523. (April 2020). Bibcode: 2020Natur.580..517T. doi:10.1038/s41586-020-2209-9. PMC 8235024. PMID 32322066.

nejm.org (Global: 2,374^th place; Japanese: 2,486^th place)

“[Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma”] (English). N Engl J Med: 987-996. (March 2005). doi:10.1056/NEJMoa043330.

nih.gov (Global: 4^th place; Japanese: 24^th place)

pubmed.ncbi.nlm.nih.gov

Stevens MF, Hickman JA, Langdon SP, Chubb D, Vickers L, Stone R, Baig G, Goddard C et al. (November 1987). “Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine”. Cancer Res. 47 (22): 5846–52. PMID 3664486.
Jacinto, FV; Esteller, M (August 2007). “MGMT hypermethylation: a prognostic foe, a predictive friend.”. DNA Repair 6 (8): 1155–60. doi:10.1016/j.dnarep.2007.03.013. PMID 17482895.
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (March 2005). “MGMT gene silencing and benefit from temozolomide in glioblastoma”. N. Engl. J. Med. 352 (10): 997–1003. doi:10.1056/NEJMoa043331. PMID 15758010.
National Cancer Institute Of Canada Clinical Trials, Group; Hegi, ME; Mason, WP; Van Den Bent, MJ; Taphoorn, MJ; Janzer, RC; Ludwin, SK; Allgeier, A et al. (May 2009). “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial”. Lancet Oncology 10 (5): 459–466. doi:10.1016/S1470-2045(09)70025-7. PMID 19269895.
“Balancing repair and tolerance of DNA damage caused by alkylating agents”. Nature Reviews. Cancer 12 (2): 104–120. (January 2012). doi:10.1038/nrc3185. PMC 3586545. PMID 22237395.
“DNA mismatch repair and the DNA damage response”. DNA Repair 38: 94–101. (February 2016). doi:10.1016/j.dnarep.2015.11.019. PMC 4740233. PMID 26704428.
“MGMT hypermethylation: a prognostic foe, a predictive friend”. DNA Repair 6 (8): 1155–1160. (August 2007). doi:10.1016/j.dnarep.2007.03.013. PMID 17482895.
“MGMT gene silencing and benefit from temozolomide in glioblastoma”. The New England Journal of Medicine 352 (10): 997–1003. (March 2005). doi:10.1056/NEJMoa043331. PMID 15758010. オリジナルの26 April 2019時点におけるアーカイブ。 2022年4月9日閲覧。.
“Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial”. The Lancet. Oncology 10 (5): 459–466. (May 2009). doi:10.1016/S1470-2045(09)70025-7. PMID 19269895.
“[Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide”] (French). Gynecol Obstet Fertil 38 (11): 660–2. (November 2010). doi:10.1016/j.gyobfe.2010.09.002. PMID 21030284.
Gilbert MR (March 2006). “New treatments for malignant gliomas: careful evaluation and cautious optimism required”. Ann. Intern. Med. 144 (5): 371–3. doi:10.7326/0003-4819-144-5-200603070-00015. PMID 16520480.
Pyrko P, Schönthal AH, Hofman FM, Chen TC, Lee AS (October 2007). “The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas”. Cancer Res. 67 (20): 9809–16. doi:10.1158/0008-5472.CAN-07-0625. PMID 17942911.
Sheehan J, Cifarelli C, Dassoulas K, Olson C, Rainey J, Han S (2010). “Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide”. Journal of Neurosurgery 113 (2): 234–239. doi:10.3171/2009.11.JNS091314. PMID 20001586.
Ueno T, Ko SH, Grubbs E, and others (March 2006). “Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine”. Mol. Cancer Ther. 5 (3): 732–8. doi:10.1158/1535-7163.MCT-05-0098. PMID 16546988.
Friedman, HS; Jiang, SX; Reardon, DA; Desjardins, A; Vredenburgh, JJ; Rich, JN; Gururangan, S; Friedman, AH et al. (March 2009). “Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma”. J. Clin. Oncol. 27 (8): 1262–7. doi:10.1200/JCO.2008.18.8417. PMC 2667825. PMID 19204199.
Dall'oglio S, D'Amico A, Pioli F, Gabbani M, Pasini F, Passarin MG, Talacchi A, Turazzi S, Maluta S (December 2008). “Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas”. J Neurooncol 90 (3): 315–9. doi:10.1007/s11060-008-9663-9. PMID 18688571.
“New treatments for malignant gliomas: careful evaluation and cautious optimism required”. Annals of Internal Medicine 144 (5): 371–373. (March 2006). doi:10.7326/0003-4819-144-5-200603070-00015. PMID 16520480.
“The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas”. Cancer Research 67 (20): 9809–9816. (October 2007). doi:10.1158/0008-5472.CAN-07-0625. PMID 17942911.
“Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide”. Journal of Neurosurgery 113 (2): 234–239. (August 2010). doi:10.3171/2009.11.JNS091314. PMID 20001586.
“Mechanisms and therapeutic implications of hypermutation in gliomas”. Nature 580 (7804): 517–523. (April 2020). Bibcode: 2020Natur.580..517T. doi:10.1038/s41586-020-2209-9. PMC 8235024. PMID 32322066.
Osmani AH, Masood N; Masood (2012). “Temozolomide for relapsed primary CNS lymphoma”. J Coll Physicians Surg Pak 22 (9): 594–595. PMID 22980617.

pmc.ncbi.nlm.nih.gov

“Balancing repair and tolerance of DNA damage caused by alkylating agents”. Nature Reviews. Cancer 12 (2): 104–120. (January 2012). doi:10.1038/nrc3185. PMC 3586545. PMID 22237395.
“DNA mismatch repair and the DNA damage response”. DNA Repair 38: 94–101. (February 2016). doi:10.1016/j.dnarep.2015.11.019. PMC 4740233. PMID 26704428.
Friedman, HS; Jiang, SX; Reardon, DA; Desjardins, A; Vredenburgh, JJ; Rich, JN; Gururangan, S; Friedman, AH et al. (March 2009). “Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma”. J. Clin. Oncol. 27 (8): 1262–7. doi:10.1200/JCO.2008.18.8417. PMC 2667825. PMID 19204199.
“Mechanisms and therapeutic implications of hypermutation in gliomas”. Nature 580 (7804): 517–523. (April 2020). Bibcode: 2020Natur.580..517T. doi:10.1038/s41586-020-2209-9. PMC 8235024. PMID 32322066.

springerlink.com (Global: 2,569^th place; Japanese: 2,101^st place)

Dall'oglio S, D'Amico A, Pioli F, Gabbani M, Pasini F, Passarin MG, Talacchi A, Turazzi S, Maluta S (December 2008). “Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas”. J Neurooncol 90 (3): 315–9. doi:10.1007/s11060-008-9663-9. PMID 18688571.

unil.ch (Global: 9,112^th place; Japanese: low place)

serval.unil.ch

“MGMT gene silencing and benefit from temozolomide in glioblastoma”. The New England Journal of Medicine 352 (10): 997–1003. (March 2005). doi:10.1056/NEJMoa043331. PMID 15758010. オリジナルの26 April 2019時点におけるアーカイブ。 2022年4月9日閲覧。.

web.archive.org (Global: 1^st place; Japanese: 1^st place)

“MGMT gene silencing and benefit from temozolomide in glioblastoma”. The New England Journal of Medicine 352 (10): 997–1003. (March 2005). doi:10.1056/NEJMoa043331. PMID 15758010. オリジナルの26 April 2019時点におけるアーカイブ。 2022年4月9日閲覧。.

テモゾロミド (Japanese Wikipedia)

aacrjournals.org (Global: 8,869^th place; Japanese: low place)

cancerres.aacrjournals.org

mct.aacrjournals.org

clinicaltrials.gov (Global: 5,225^th place; Japanese: low place)

doi.org (Global: 2^nd place; Japanese: 6^th place)

elsevier.com (Global: 610^th place; Japanese: 915^th place)

linkinghub.elsevier.com

fhcrc.org (Global: low place; Japanese: low place)

labs.fhcrc.org

harvard.edu (Global: 18^th place; Japanese: 107^th place)

ui.adsabs.harvard.edu

nejm.org (Global: 2,374^th place; Japanese: 2,486^th place)

nih.gov (Global: 4^th place; Japanese: 24^th place)

pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

springerlink.com (Global: 2,569^th place; Japanese: 2,101^st place)

unil.ch (Global: 9,112^th place; Japanese: low place)

serval.unil.ch

web.archive.org (Global: 1^st place; Japanese: 1^st place)

wikipedia.org (Global: low place; Japanese: low place)

en.wikipedia.org

fr.wikipedia.org

テモゾロミド (Japanese Wikipedia)

aacrjournals.org (Global: 8,869th place; Japanese: low place)

cancerres.aacrjournals.org

mct.aacrjournals.org

clinicaltrials.gov (Global: 5,225th place; Japanese: low place)

doi.org (Global: 2nd place; Japanese: 6th place)

elsevier.com (Global: 610th place; Japanese: 915th place)

linkinghub.elsevier.com

fhcrc.org (Global: low place; Japanese: low place)

labs.fhcrc.org

harvard.edu (Global: 18th place; Japanese: 107th place)

ui.adsabs.harvard.edu

nejm.org (Global: 2,374th place; Japanese: 2,486th place)

nih.gov (Global: 4th place; Japanese: 24th place)

pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

springerlink.com (Global: 2,569th place; Japanese: 2,101st place)

unil.ch (Global: 9,112th place; Japanese: low place)

serval.unil.ch

web.archive.org (Global: 1st place; Japanese: 1st place)

wikipedia.org (Global: low place; Japanese: low place)

en.wikipedia.org

fr.wikipedia.org

aacrjournals.org (Global: 8,869^th place; Japanese: low place)

clinicaltrials.gov (Global: 5,225^th place; Japanese: low place)

doi.org (Global: 2^nd place; Japanese: 6^th place)

elsevier.com (Global: 610^th place; Japanese: 915^th place)

harvard.edu (Global: 18^th place; Japanese: 107^th place)

nejm.org (Global: 2,374^th place; Japanese: 2,486^th place)

nih.gov (Global: 4^th place; Japanese: 24^th place)

springerlink.com (Global: 2,569^th place; Japanese: 2,101^st place)

unil.ch (Global: 9,112^th place; Japanese: low place)

web.archive.org (Global: 1^st place; Japanese: 1^st place)